Journals / ENTcase / 2016 / Cilt: 2 - Sayı: 1

PERIPHERAL T-CELL LYMPHOMA LOCATED IN THE SOFT PALATE

YUMUŞAK DAMAK YERLEŞİMLİ PERİFERİK T HÜCRELİ LENFOMA

Journal
ENTcase
Pages
16–20
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Peripheral T cell lymphomas are a heterogeneous group of clinically aggressive diseases associatedwithpoorprognosis.Therefore,itshouldbe aware of a more serious underlying disease in treatment-resistantcases.Theaimofthiscasereportis to emphasize the necessity of re-evaluation of the diagnosis, especially in treatment-resistant cases.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Common complaints or findings that are encountered in ENT daily practice might be associated with more serious diseases.
📊
Key Findings & Data:In this case report, we present a 48-year old female patient presenting with symptoms ofnasalobstructionandsnoringthatdonotrespondto previous treatments.
💡
Conclusion & Impact:Peripheral T cell lymphomas are a heterogeneous group of clinically aggressive diseases associatedwithpoorprognosis.Therefore,itshouldbe aware of a more serious underlying disease in treatment-resistantcases.Theaimofthiscasereportis to emphasize the necessity of re-evaluation of the diagnosis, especially in treatment-resistant cases.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Common complaints or findings that are encountered in ENT daily practice might be associated with more serious diseases. In this case report, we present a 48-year old female patient presenting with symptoms ofnasalobstructionandsnoringthatdonotrespondto previous treatments. The patient was diagnosed peripheral T cell lymphoma in soft palate with punch biopsy. Peripheral T cell lymphomas are a heterogeneous group of clinically aggressive diseases associatedwithpoorprognosis.Therefore,itshouldbe aware of a more serious underlying disease in treatment-resistantcases.Theaimofthiscasereportis to emphasize the necessity of re-evaluation of the diagnosis, especially in treatment-resistant cases.

Özet

Günlük KBB Hastalıkları pratiğinde sık karşılaşılan bir yakınma veya bulgunun, çok daha ciddi bir hastalığın habercisi olduğu, yoğun poliklinik şartlarında gözden kaçabilir. Bu olgu sunumunda tedaviye yanıt vermeyen buruntıkanıklığıvehorlamayakınmalarıylabaşvuranve punchbiyopsiileyumuşakdamakyerleşimliperiferikT hücreli lenfoma tanısı konan 48 yaşında kadın hasta sunulmaktadır.PeriferikThücrelilenfomalar,Thücreli non-Hodgkin lenfomaların içinde yer alan ve kötü prognoza sahip heterojen bir hastalık grubudur. Nadir görülürlervetedaviedilmezlersesağkalımsüreleriaylarla sınırlıdır. Bu nedenle rutin KBB pratiğinde, özellikle tedaviyedirençliolgularda,alttadahaciddibirhastalığın olabileceğiaklagetirilmeli,muayenevetetkikaşamaları dikkatlivehızlışekildetekrargözdengeçirilmelidir.Bu olgusunumu,tedaviyebeklediğimizyanıtıalamadığımız hastalarımızda, tanının tekrar gözden geçirilmesinin ve tanı aşamalarının hızlı bir şekilde yürütülmesinin gerekliliğini vurgulamak amacıyla yapılmıştır.

🔖

Cite This Article

EĞRİLMEZ, M., DOKUZLAR, U., DENİZOĞLU, İ. İ., OCAKÇI, S., ŞAHİN, E. (2016). PERIPHERAL T-CELL LYMPHOMA LOCATED IN THE SOFT PALATE. ENTcase, Cilt: 2 - Sayı: 1, 16–20. https://ajindex.com/articles/154437

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Foss FM, et al. Peripheral T-cell lymphoma. Blood 2011; 117: 6756-67.
  2. Moskowitz AJ, Lunning MA, Horwitz SM. How I treat the peripheral T-cell lymphomas. Blood 2014; 123: 2636-44.
  3. Swerdlow SH, Campo E, Harris NL, et al. (Eds). World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. IARC Press, Lyon 2008. Weisenburger DD, et al. Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project. Blood 2011; 117: 3402-08. Sonnen R, et al. The International Prognostic Index determines the outcome of patients with nodal mature T-cell lymphomas. Br J Haematol 2005; 129: 366-72. Escalón MP, et al. Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience. Cancer 2005; 103: 2091-8. Smith SM, et al. Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma. J Clin Oncol 2013; 31: 3100-9.